Browsing Over 107 Presentations
Sort By
Managing the consequences of cancer treatments
Clinical case session
How to optimise older patients for cancer treatments?
Lecture Time
14:35 - 14:55
Speakers
- Claire Falandry (Pierre Benite, France)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
14:15 - 15:45
Eisai - Recent advances in the management of endometrial cancer and their impact on the clinical practice
Industry satellite symposium
Opening & Introduction
Lecture Time
18:00 - 18:05
Speakers
- Ana Oaknin (Barcelona, Spain)
Session Name
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
18:00 - 19:00
Mini Oral session
Abstract session
Invited Discussant of abstracts 21MO and 27MO
Lecture Time
13:25 - 13:35
Speakers
- Iain McNeish (london, United Kingdom)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
13:00 - 14:00
Ovarian cancer management in the PARP inhibitor era
Educational session
The role of surgery in newly-diagnosed and recurrent ovarian cancer in the era of targeted therapies
Lecture Time
16:15 - 16:40
Speakers
- Sven Mahner (Munich, Germany)
Session Name
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
16:15 - 17:45
Clinical trial highlights
Special session
Invited Discussant of SIENDO/ENGOT-EN5 and MITO 23 studies
Lecture Time
11:35 - 11:50
Speakers
- Isabelle L. Ray-Coquard (Lyon, France)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Keynote lecture: Changes in practice and research breakthroughs in the treatment of gynaecological cancers
Keynote session
Changes in practice and research breakthroughs in the treatment of gynaecological cancers
Lecture Time
14:20 - 14:40
Speakers
- Eric Pujade-Lauraine (Paris, France)
Session Name
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
14:15 - 14:45
Clinical trial highlights
Special session
ATHENA (GOG-3020/ENGOT-ov45): A randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer
Lecture Time
10:40 - 10:50
Speakers
- Rebecca Kristeleit (London, United Kingdom)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
GSK - Using biomarkers to guide targeted therapy in gynaecological cancers
Industry satellite symposium
Welcome and introduction
Lecture Time
13:00 - 13:05
Speakers
- Ana Oaknin (Barcelona, Spain)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
13:00 - 14:00
The evolving landscape in cervical cancer treatment
Educational session
Surgical approach in early-stage cervical cancer: Keeping the principles and reducing morbidity
Lecture Time
08:30 - 08:55
Speakers
- David Cibula (Prague, Czech Republic)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
08:30 - 10:00
Biomarkers in clinical practice and future perspective for gynaecological cancers
Special session
Should we really use PD-L1 as a selection driver in cervical cancer?
Lecture Time
10:30 - 10:50
Speakers
- Bradley J. Monk (Phoenix, AZ, United States of America)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
10:30 - 12:00
Rare gynaecological cancers
Educational session
Discussion
Lecture Time
17:25 - 17:40
Speakers
- Isabelle L. Ray-Coquard (Lyon, France)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
16:10 - 17:40
Management of endometrial cancer in the molecular era
Educational session
Introduction
Lecture Time
08:30 - 08:35
Speakers
- Mansoor Raza Mirza (Copenhagen, Denmark)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
08:30 - 10:00